Andrew Newland

Andrew Newland

Founder at
Novocellus Ltd.

Net worth: 211 690 $ as of 2026-05-30

65 year
Health Technology
Distribution Services
Consumer Services

Profile

Mr. Andrew D.
Newland is a Chairman at NeuroTargets Ltd., a Chairman at Novocellus Ltd. and a Chairman at Parsortix, Inc. He is on the Board of Directors at ANGLE Europe Ltd. and Arenko Cleantech Ltd. Mr. Newland was previously employed as a Chief Executive Officer by ANGLE Plc, a Chairman by Provexis Ltd., and a Chairman by Acolyte Biomedica Ltd. He received his graduate degree from the University of Cambridge.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-30 7,304,686 ( 0.64% ) 211 690 $ 2026-05-30

Andrew Newland active positions

CompaniesPositionStart
Chairman -
Novocellus Ltd.
Founder -
Parsortix, Inc.
Chairman -
Director/Board Member -
Director/Board Member 2006-04-25

Former positions of Andrew Newland

CompaniesPositionEnd
CELLBXHEALTH PLC Founder 2025-09-11
Chairman 2004-12-31
Founder -
See the detail of Andrew Newland's experience

Training of Andrew Newland

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

25

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Distribution Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Novocellus Ltd.

Parsortix, Inc.

Industrial Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Andrew Newland